{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:12:49Z","timestamp":1790140369899,"version":"4.0.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"\n Importance<\/jats:title>\n Requiring personalized genetic counseling may introduce barriers to cancer risk assessment, but it is unknown whether omitting counseling could increase distress.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess whether omitting pretest and\/or posttest genetic counseling would increase distress during remote testing.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Making Genetic Testing Accessible (MAGENTA) was a 4-arm, randomized noninferiority trial testing the effects of individualized pretest and\/or posttest genetic counseling on participant distress 3 and 12 months posttest. Participants were recruited via social and traditional media, and enrollment occurred between April 27, 2017, and September 29, 2020. Participants were women aged 30 years or older, English-speaking, US residents, and had access to the internet and a health care professional. Previous cancer genetic testing or counseling was exclusionary. In the family history cohort, participants had a personal or family history of breast or ovarian cancer. In the familial pathogenic variant (PV) cohort, participants reported 1 biological relative with a PV in an actionable cancer susceptibility gene. Data analysis was performed between December 13, 2020, and May 31, 2023.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Participants completed baseline questionnaires, watched an educational video, and were randomized to 1 of 4 arms: the control arm with pretest and\/or posttest genetic counseling, or 1 of 3 study arms without pretest and posttest counseling. Genetic counseling was provided by phone appointments and testing was done using home-delivered saliva kits.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was participant distress measured by the Impact of Event Scale 3 months after receiving the results. Secondary outcomes included completion of testing, anxiety, depression, and decisional regret.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 3839 women (median age, 44 years [range 22-91 years]), most of whom were non-Hispanic White and college educated, were randomized, 3125 in the family history and 714 in the familial PV cohorts. In the primary analysis in the family history cohort, all experimental arms were noninferior for distress at 3 months. There were no statistically significant differences in anxiety, depression, or decisional regret at 3 months. The highest completion rates were seen in the 2 arms without pretest counseling.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In the MAGENTA clinical trial, omitting individualized pretest counseling for all participants and posttest counseling for those without PV during remote genetic testing was not inferior with regard to posttest distress, providing an alternative care model for genetic risk assessment.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT02993068<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2023.3748","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T11:19:38Z","timestamp":1694690378000},"page":"1547","source":"Crossref","is-referenced-by-count":55,"title":["Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial"],"prefix":"10.1001","volume":"9","author":[{"given":"Elizabeth M.","family":"Swisher","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Rayes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Bowen","sequence":"additional","affiliation":[{"name":"Department of Bioethics and Humanities, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Norquist","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Coffin","sequence":"additional","affiliation":[{"name":"Department of Bioethics and Humanities, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Gavin","sequence":"additional","affiliation":[{"name":"Minnesota Ovarian Cancer Alliance, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Polinsky","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Crase","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie N.","family":"Bakkum-Gamez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie V.","family":"Blank","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Munsell","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Nebgen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gini F.","family":"Fleming","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherman","family":"Law","sequence":"additional","affiliation":[{"name":"Color Health, Burlingame, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Color Health, Burlingame, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Levine","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center, NYU Langone Health, New York, New York"},{"name":"Now with Merck Research Laboratories, Rahway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"Dana Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"coi230047r1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"coi230047r2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7326\/0003-4819-143-5-200509060-00011","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.","volume":"143","author":"US Preventive Services Task Force","year":"2005","journal-title":"Ann Intern Med"},{"issue":"8","key":"coi230047r3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/jnci\/djz008","article-title":"Trends in BRCA test utilization in an integrated health system, 2005-2015.","volume":"111","author":"Knerr","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"coi230047r4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.amepre.2014.01.002","article-title":"Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.","volume":"46","author":"Mai","year":"2014","journal-title":"Am J Prev Med"},{"key":"coi230047r5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3389\/fpubh.2017.00195","article-title":"Barriers and facilitating factors for implementation of genetic services: a public health perspective.","volume":"5","author":"Cornel","year":"2017","journal-title":"Front Public Health"},{"issue":"4","key":"coi230047r6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10897-013-9668-1","article-title":"Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.","volume":"23","author":"Radford","year":"2014","journal-title":"J Genet Couns"},{"issue":"1","key":"coi230047r7","doi-asserted-by":"publisher","DOI":"10.2196\/23523","article-title":"Barriers and facilitators to genetic service delivery models: scoping review.","volume":"10","author":"Raspa","year":"2021","journal-title":"Interact J Med Res"},{"issue":"15","key":"coi230047r8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","article-title":"Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients.","volume":"37","author":"Kurian","year":"2019","journal-title":"J Clin Oncol"},{"issue":"14","key":"coi230047r9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer.","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"coi230047r10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk.","volume":"13","author":"Levy","year":"2011","journal-title":"Genet Med"},{"issue":"12","key":"coi230047r11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju328","article-title":"Expanding access to BRCA1\/2 genetic counseling with telephone delivery: a cluster randomized trial.","volume":"106","author":"Kinney","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi230047r12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10689-016-9900-x","article-title":"Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast\/ovarian cancer.","volume":"15","author":"Jacobs","year":"2016","journal-title":"Fam Cancer"},{"issue":"24","key":"coi230047r13","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1200\/JCO.2015.65.9557","article-title":"Randomized noninferiority trial of telephone delivery of BRCA1\/2 genetic counseling compared with in-person counseling: 1-year follow-up.","volume":"34","author":"Kinney","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi230047r14","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkx002","article-title":"Randomized noninferiority trial of telephone vs in-person genetic counseling for hereditary breast and ovarian cancer: a 12-month follow-up.","volume":"1","author":"Interrante","year":"2017","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"3","key":"coi230047r15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10689-012-9522-x","article-title":"The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees\u2019 outcome.","volume":"11","author":"Platten","year":"2012","journal-title":"Fam Cancer"},{"issue":"1","key":"coi230047r16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12885-019-5868-x","article-title":"MAGENTA (Making Genetic Testing Accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.","volume":"19","author":"Rayes","year":"2019","journal-title":"BMC Cancer"},{"issue":"9","key":"coi230047r17","doi-asserted-by":"publisher","DOI":"10.2196\/35035","article-title":"Using social media to facilitate communication about women\u2019s testing: tool validation study.","volume":"6","author":"Coffin","year":"2022","journal-title":"JMIR Form Res"},{"issue":"2","key":"coi230047r18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)a\u2014 metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"7","key":"coi230047r19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JCO.2013.51.3226","article-title":"Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.","volume":"32","author":"Schwartz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi230047r21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","article-title":"Impact of Event Scale: a measure of subjective stress.","volume":"41","author":"Horowitz","year":"1979","journal-title":"Psychosom Med"},{"issue":"12","key":"coi230047r22","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/pon.v24.12","article-title":"The impact of events scale: a comparison of frequency versus severity approaches to measuring cancer-specific distress.","volume":"24","author":"Salsman","year":"2015","journal-title":"Psychooncology"},{"issue":"10","key":"coi230047r23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7.","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1-3","key":"coi230047r24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population.","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"issue":"1","key":"coi230047r25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11136-008-9418-2","article-title":"Updated US population standard for the Veterans RAND 12-item Health Survey (VR-12).","volume":"18","author":"Selim","year":"2009","journal-title":"Qual Life Res"},{"issue":"4","key":"coi230047r26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","article-title":"Validation of a decision regret scale.","volume":"23","author":"Brehaut","year":"2003","journal-title":"Med Decis Making"},{"issue":"5","key":"coi230047r27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes\u2014association analysis in more than 113,000 women.","volume":"384","author":"Dorling","year":"2021","journal-title":"N Engl J Med"},{"issue":"15","key":"coi230047r28","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.22.00751","article-title":"Improving uptake of cancer genetic risk assessment in a remote tailored risk communication and navigation intervention: large effect size but room to grow.","volume":"41","author":"Kinney","year":"2023","journal-title":"J Clin Oncol"},{"key":"coi230047r29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ygyno.2023.04.001","article-title":"Web-based tool for cancer family history collection: a prospective randomized controlled trial.","volume":"173","author":"Frey","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"7","key":"coi230047r30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22092","article-title":"Patient and clinician decision support to increase genetic counseling for hereditary breast and ovarian cancer syndrome in primary care: a cluster randomized clinical trial.","volume":"5","author":"Kukafka","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"13","key":"coi230047r31","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/cncr.32032","article-title":"Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: a randomized controlled trial.","volume":"125","author":"Esplen","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"coi230047r32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12913-018-3442-x","article-title":"Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1\/2 genetic counseling referral in primary care.","volume":"18","author":"Silverman","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"coi230047r33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/jnci\/djy015","article-title":"Randomized noninferiority trial of telephone vs in-person disclosure of germline cancer genetic test results.","volume":"110","author":"Bradbury","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"coi230047r34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer.","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"coi230047r35","doi-asserted-by":"publisher","DOI":"10.2196\/34055","article-title":"An accessible communication system for population-based genetic testing: development and usability study.","volume":"6","author":"Coffin","year":"2022","journal-title":"JMIR Form Res"},{"issue":"3","key":"coi230047r36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jgc4.v28.3","article-title":"Racial and ethnic differences in knowledge and attitudes about genetic testing in the US: systematic review.","volume":"28","author":"Canedo","year":"2019","journal-title":"J Genet Couns"},{"issue":"3","key":"coi230047r37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12687-022-00590-3","article-title":"Attitudes and interest in incorporating BRCA1\/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.","volume":"13","author":"Hardy","year":"2022","journal-title":"J Community Genet"},{"issue":"2","key":"coi230047r38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cge.2019.95.issue-2","article-title":"Preferences for in-person disclosure: patients declining telephone disclosure characteristics and outcomes in the multicenter Communication of Genetic Test Results by Telephone study.","volume":"95","author":"Beri","year":"2019","journal-title":"Clin Genet"},{"issue":"3","key":"coi230047r39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10897-015-9897-6","article-title":"Patient perceptions of telephone vs in-person BRCA1\/BRCA2 genetic counseling.","volume":"25","author":"Peshkin","year":"2016","journal-title":"J Genet Couns"},{"key":"coi230047r20","unstructured":"Color\u2014Genetic Testing for Hereditary Cancer Risk. Accessed August 10, 2023. https:\/\/www.youtube.com\/watch?v=ntD7iT64bPM"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2809581\/jamaoncology_swisher_2023_oi_230047_1699901581.43686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T11:06:13Z","timestamp":1700132773000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2809581"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.3748","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}